Company page

China Regenerative Medicine International Limited

China Regenerative Medicine International Limited, trading under the ticker 8158 on the Hong Kong Stock Exchange, focuses on the development and commercialization of regenerative medicine technologies. The company has a market capitalization of approximately HKD 14.37 million. Its efforts are centered on innovative medical solutions aimed at improving patient outcomes.